THE FOLLOWING INFORMATION WAS OBTAINED FROM THE PHYSICIAN REGISTER SECTION OF THE WEBSITE OF THE COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO (WWW.CPSO.ON.CA) AS OF THE DATE AND TIME NOTED BELOW
19/04/26 11:11:05 AM

General Information

Former Name: No Former Name
Medical School: St. George's University School of Medicine, 1992
Gender: Man
Languages Spoken: ENGLISH

Practice Information

Primary Business Location: 1017 Wilson Avenue
Suite 102
Toronto Ontario M3K 1Z1
Business Email: No Information Available
Phone: 4163984707
Fax: 4163984700

Specialties

No Specialty Reported

Hospital Privileges

No information available

Professional Corporation Information

Corporation Name: David Barrett Medicine Professional Corporation
Certificate of Authorization Status: Issued Date: 19 Apr 2005
Shareholders:
Dr. D. Barrett (CPSO#: 80252 )
Business Address: Regent Medical Clinic
102 - 2737 Keele Street
Toronto Ontario M3M 2E9
(416) 398-4500
Business Address: 1017 Wilson Ave
Regent Medical Clinic
102
North York ON M3K 1Z1

General Information

Former Name: No Former Name
Gender: Man
Languages Spoken: ENGLISH
Medical School: St. George's University School of Medicine, 1992

Practice Information

Primary Business Location: 1017 Wilson Avenue
Suite 102
Toronto Ontario M3K 1Z1
Business Email: No Information Available
Phone: 4163984707
Fax: 4163984700

Specialties

No Specialty Reported

Hospital Privileges

No information available

Professional Corporation Information

Corporation Name: David Barrett Medicine Professional Corporation
Certificate of Authorization Status: Issued Date: 19 Apr 2005
Shareholders:
Dr. D. Barrett (CPSO#: 80252 )
Business Address: Regent Medical Clinic
102 - 2737 Keele Street
Toronto Ontario M3M 2E9
(416) 398-4500
Business Address: 1017 Wilson Ave
Regent Medical Clinic
102
North York ON M3K 1Z1

Practice Conditions

IMPOSED BY EFFECTIVE DATE EXPIRY DATE STATUS
Member
10 Nov 2025
Restricted
IMPOSED BY: Member
EFFECTIVE DATE: 10 Nov 2025
EXPIRY DATE:
STATUS: Restricted
A physician who has a restricted licence must follow specific terms and conditions in their practice.
A physician who has a restricted licence must follow specific terms and conditions in their practice.
VIEW DETAILS chevron-down icon
As from July 26th, 2019, the following terms, conditions and limitations are imposed on the certificate of registration held by Dr. David Jang Barrett, in accordance with an undertaking and consent Dr. Barrett has given to the College of Physicians and Surgeons of Ontario:

UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT
(“Undertaking”)

of

DR. DAVID JANG BARRETT
(“Dr. Barrett”)

to

COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
(the “College”)

A. PREAMBLE

(1) In this Undertaking:

"Code" means the Health Professions Procedural Code, which is Schedule 2 to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as amended;
"NMS" means the Drug Program Services Branch, the Narcotics Monitoring System implemented under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22, as amended;
"OHIP" means the Ontario Health Insurance Plan;
"Public Register" means the College's register that is available to the public.

(2) I, Dr. Barrett, certificate of registration number 80252, am a member of the College.

(3) I, Dr. Barrett, acknowledge that following a report that raised concerns about my standard of practice in prescribing narcotics and controlled substances the College conducted an investigation bearing File Number 1102376 (the "Investigation").

B. UNDERTAKING

(4) I, Dr. Barrett, undertake to abide by the provisions of this Undertaking, effective immediately.

(5) Resignation of Prescribing Privileges

(a) I, Dr. Barrett, acknowledge that I have executed the Prescribing Resignation Letter to Health Canada, which is attached hereto as Schedule "A" (the "Resignation Letter").

(b) I, Dr. Barrett, consent to the College sending the Resignation Letter to Health Canada on my behalf.

(c) I, Dr. Barrett, undertake that I will not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c.19);
(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C.,1996, c. 19);
(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);
(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C.,1996, c. 19);

(A summary of the above-named drugs [from Appendix I to the Compendium of Pharmaceuticals and Specialties] is attached hereto as Schedule "B"; and links to the current regulatory lists are attached hereto as Schedule "C")

(v) Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22, with a link to the current regulatory list attached hereto as Schedule "D"); and as amended from time to time.

(d) I, Dr. Barrett, undertake to immediately refer all patients to whom I am prescribing any of the substances described in section (c), above, to other physicians for assessment and care.

(e) I, Dr. Barrett, undertake to keep a log of all patients referred to other physicians pursuant to section (d), above (the "Log"). I, Dr. Barrett, undertake to include in the Log the name of each patient referred, the name of the physician referred to, and the date of referral.

(6) I, Dr. Barrett, undertake that I will return any supplies of the substances referred to in section (5)(c) above that are presently in my possession, in any place, to a pharmacy in a safe and secure manner, as stipulated in the College's Policy Number 8-12, "Prescribing Drugs."

(7) I, Dr. Barrett, undertake to inform the College of each and every location that I practise or have privileges, including, but not limited to, any hospitals, clinics, offices, and any Independent Health Facilities with which I am affiliated, in any jurisdiction (collectively my "Practice Location" or "Practice Locations"), within five (5) days of executing this Undertaking. Going forward, I further undertake to inform the College of any and all new Practice Locations within five (5) days of commencing practice at that location.

(8) Posting a Sign

(a) I, Dr. Barrett, undertake that I shall post a sign in all waiting rooms and in each examination and consulting room, in all my Practice Locations, in a clearly visible and secure location, in the form set out at Schedule "E." For further clarity, this sign shall state as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:

Narcotic Drugs
Narcotic Preparations
Controlled Drugs
Benzodiazepines and Other Targeted Substances
Monitored Drugs

Further information may be found on the College of Physicians and Surgeons of Ontario website at www.cpso.on.ca

(b) I, Dr. Barrett, undertake to post a certified translation in any language in which I provide services, of the sign described in section (8)(a) above, in all waiting rooms and in each examination and consulting room, in all my Practice Locations, in a clearly visible and secure location, in the form set out at Schedule "E."

(c) I, Dr. Barrett, undertake to provide the certified translation described in section (8)(b), to the College within thirty (30) days of executing this Undertaking.

(d) I, Dr. Barrett, undertake that if I elect, after the execution of this Undertaking, to provide services in any other language, I will notify the College prior to providing any such services.

(e) I, Dr. Barrett, undertake to provide to the College the certified translation described in section (8)(c) prior to beginning to provide services in any language described in section (8)(d).

C. ACKNOWLEDGEMENT

(9) I, Dr. Barrett, acknowledge that all schedules attached to or referred to in this Undertaking form part of this Undertaking.

(10) I, Dr. Barrett, acknowledge and undertake that I shall be solely responsible for payment of all fees, costs, charges, expenses, etc. arising from the implementation of any of the provisions of this Undertaking.

(11) I, Dr. Barrett, acknowledge that I have read and understand the provisions of this Undertaking and that I have obtained independent legal counsel in reviewing and executing this Undertaking, or have waived my right to do so.

(12) I, Dr. Barrett, acknowledge that the College will provide this Undertaking to any Chief of Staff, or a colleague with similar responsibilities, at any Practice Location ("Chief of Staff" or "Chiefs of Staff").

(13) I, Dr. Barrett, acknowledge that a breach by me of any provision of this Undertaking may constitute an act of professional misconduct and/or incompetence, and may result in a referral of specified allegations to the Discipline Committee.

(14) I, Dr. Barrett, acknowledge that this Undertaking constitutes terms, conditions, and limitations on my certificate of registration for the purposes of section 23 of the Code.

(15) Public Register

(a) I, Dr. Barrett, acknowledge that, during the time period that this Undertaking remains in effect, this Undertaking shall be posted on the Public Register.

(b) I, Dr. Barrett, acknowledge that, in addition to this Undertaking being posted in accordance with section (15)(a) above, the following summary shall be posted on the Public Register during the time period that this Undertaking remains in effect:

A College investigation was conducted into Dr. Barrett's prescribing of
narcotics and controlled substances. As a result of the investigation:

Dr. Barrett must not issue new prescriptions or renew existing
prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under
the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(ii) Narcotic Preparations (from the Narcotic Control Regulations made
under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(iii) Controlled Drugs (from Part G of the Food and Drug Regulations
under the Food and Drugs Act, S.C., 1985, c. F-27);

(iv) Benzodiazepines and Other Targeted Substances (from the
Benzodiazepines and Other Targeted Substances Regulations made
under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);

(v) Monitored Drugs (as defined under the Narcotics Safety and
Awareness Act, 2010, S.O. 2010, c. 22); and as amended from time to time.

Dr. Barrett must post a clearly visible sign in the waiting rooms and
each examination and consulting room, in all Practice Locations, which
states as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:
- Narcotic Drugs
- Narcotic Preparations
- Controlled Drugs
- Benzodiazepines and Other Targeted Substances
- Monitored Drugs

Further information may be found on the College of Physicians and
Surgeons of Ontario website at www.cpso.on.ca

D. CONSENT

(16) I, Dr. Barrett, undertake that I will submit to, and not interfere with, unannounced inspections of my Practice Locations and patient charts by the College and to any other activity the College deems necessary in order to monitor my compliance with the provisions of this Undertaking.

(17) I, Dr. Barrett, give my irrevocable consent to the College to make appropriate enquiries of OHIP, NMS, and any person who or institution that may have relevant information, in order for the College to monitor my compliance with the provisions of this Undertaking.

(18) I, Dr. Barrett, acknowledge that I have executed the OHIP and NMS consent forms, attached hereto as Schedule "F" and Schedule "G", respectively.

(19) I, Dr. Barrett, give my irrevocable consent to the College to provide all Chiefs of Staff with any information the College has that led to the circumstances of my entering into this Undertaking and any information arising from the monitoring of my compliance with this Underta

VIEW DETAILS chevron-down icon
As from July 26th, 2019, the following terms, conditions and limitations are imposed on the certificate of registration held by Dr. David Jang Barrett, in accordance with an undertaking and consent Dr. Barrett has given to the College of Physicians and Surgeons of Ontario:

UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT
(“Undertaking”)

of

DR. DAVID JANG BARRETT
(“Dr. Barrett”)

to

COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
(the “College”)

A. PREAMBLE

(1) In this Undertaking:

"Code" means the Health Professions Procedural Code, which is Schedule 2 to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as amended;
"NMS" means the Drug Program Services Branch, the Narcotics Monitoring System implemented under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22, as amended;
"OHIP" means the Ontario Health Insurance Plan;
"Public Register" means the College's register that is available to the public.

(2) I, Dr. Barrett, certificate of registration number 80252, am a member of the College.

(3) I, Dr. Barrett, acknowledge that following a report that raised concerns about my standard of practice in prescribing narcotics and controlled substances the College conducted an investigation bearing File Number 1102376 (the "Investigation").

B. UNDERTAKING

(4) I, Dr. Barrett, undertake to abide by the provisions of this Undertaking, effective immediately.

(5) Resignation of Prescribing Privileges

(a) I, Dr. Barrett, acknowledge that I have executed the Prescribing Resignation Letter to Health Canada, which is attached hereto as Schedule "A" (the "Resignation Letter").

(b) I, Dr. Barrett, consent to the College sending the Resignation Letter to Health Canada on my behalf.

(c) I, Dr. Barrett, undertake that I will not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c.19);
(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C.,1996, c. 19);
(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);
(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C.,1996, c. 19);

(A summary of the above-named drugs [from Appendix I to the Compendium of Pharmaceuticals and Specialties] is attached hereto as Schedule "B"; and links to the current regulatory lists are attached hereto as Schedule "C")

(v) Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22, with a link to the current regulatory list attached hereto as Schedule "D"); and as amended from time to time.

(d) I, Dr. Barrett, undertake to immediately refer all patients to whom I am prescribing any of the substances described in section (c), above, to other physicians for assessment and care.

(e) I, Dr. Barrett, undertake to keep a log of all patients referred to other physicians pursuant to section (d), above (the "Log"). I, Dr. Barrett, undertake to include in the Log the name of each patient referred, the name of the physician referred to, and the date of referral.

(6) I, Dr. Barrett, undertake that I will return any supplies of the substances referred to in section (5)(c) above that are presently in my possession, in any place, to a pharmacy in a safe and secure manner, as stipulated in the College's Policy Number 8-12, "Prescribing Drugs."

(7) I, Dr. Barrett, undertake to inform the College of each and every location that I practise or have privileges, including, but not limited to, any hospitals, clinics, offices, and any Independent Health Facilities with which I am affiliated, in any jurisdiction (collectively my "Practice Location" or "Practice Locations"), within five (5) days of executing this Undertaking. Going forward, I further undertake to inform the College of any and all new Practice Locations within five (5) days of commencing practice at that location.

(8) Posting a Sign

(a) I, Dr. Barrett, undertake that I shall post a sign in all waiting rooms and in each examination and consulting room, in all my Practice Locations, in a clearly visible and secure location, in the form set out at Schedule "E." For further clarity, this sign shall state as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:

Narcotic Drugs
Narcotic Preparations
Controlled Drugs
Benzodiazepines and Other Targeted Substances
Monitored Drugs

Further information may be found on the College of Physicians and Surgeons of Ontario website at www.cpso.on.ca

(b) I, Dr. Barrett, undertake to post a certified translation in any language in which I provide services, of the sign described in section (8)(a) above, in all waiting rooms and in each examination and consulting room, in all my Practice Locations, in a clearly visible and secure location, in the form set out at Schedule "E."

(c) I, Dr. Barrett, undertake to provide the certified translation described in section (8)(b), to the College within thirty (30) days of executing this Undertaking.

(d) I, Dr. Barrett, undertake that if I elect, after the execution of this Undertaking, to provide services in any other language, I will notify the College prior to providing any such services.

(e) I, Dr. Barrett, undertake to provide to the College the certified translation described in section (8)(c) prior to beginning to provide services in any language described in section (8)(d).

C. ACKNOWLEDGEMENT

(9) I, Dr. Barrett, acknowledge that all schedules attached to or referred to in this Undertaking form part of this Undertaking.

(10) I, Dr. Barrett, acknowledge and undertake that I shall be solely responsible for payment of all fees, costs, charges, expenses, etc. arising from the implementation of any of the provisions of this Undertaking.

(11) I, Dr. Barrett, acknowledge that I have read and understand the provisions of this Undertaking and that I have obtained independent legal counsel in reviewing and executing this Undertaking, or have waived my right to do so.

(12) I, Dr. Barrett, acknowledge that the College will provide this Undertaking to any Chief of Staff, or a colleague with similar responsibilities, at any Practice Location ("Chief of Staff" or "Chiefs of Staff").

(13) I, Dr. Barrett, acknowledge that a breach by me of any provision of this Undertaking may constitute an act of professional misconduct and/or incompetence, and may result in a referral of specified allegations to the Discipline Committee.

(14) I, Dr. Barrett, acknowledge that this Undertaking constitutes terms, conditions, and limitations on my certificate of registration for the purposes of section 23 of the Code.

(15) Public Register

(a) I, Dr. Barrett, acknowledge that, during the time period that this Undertaking remains in effect, this Undertaking shall be posted on the Public Register.

(b) I, Dr. Barrett, acknowledge that, in addition to this Undertaking being posted in accordance with section (15)(a) above, the following summary shall be posted on the Public Register during the time period that this Undertaking remains in effect:

A College investigation was conducted into Dr. Barrett's prescribing of
narcotics and controlled substances. As a result of the investigation:

Dr. Barrett must not issue new prescriptions or renew existing
prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under
the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(ii) Narcotic Preparations (from the Narcotic Control Regulations made
under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(iii) Controlled Drugs (from Part G of the Food and Drug Regulations
under the Food and Drugs Act, S.C., 1985, c. F-27);

(iv) Benzodiazepines and Other Targeted Substances (from the
Benzodiazepines and Other Targeted Substances Regulations made
under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);

(v) Monitored Drugs (as defined under the Narcotics Safety and
Awareness Act, 2010, S.O. 2010, c. 22); and as amended from time to time.

Dr. Barrett must post a clearly visible sign in the waiting rooms and
each examination and consulting room, in all Practice Locations, which
states as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:
- Narcotic Drugs
- Narcotic Preparations
- Controlled Drugs
- Benzodiazepines and Other Targeted Substances
- Monitored Drugs

Further information may be found on the College of Physicians and
Surgeons of Ontario website at www.cpso.on.ca

D. CONSENT

(16) I, Dr. Barrett, undertake that I will submit to, and not interfere with, unannounced inspections of my Practice Locations and patient charts by the College and to any other activity the College deems necessary in order to monitor my compliance with the provisions of this Undertaking.

(17) I, Dr. Barrett, give my irrevocable consent to the College to make appropriate enquiries of OHIP, NMS, and any person who or institution that may have relevant information, in order for the College to monitor my compliance with the provisions of this Undertaking.

(18) I, Dr. Barrett, acknowledge that I have executed the OHIP and NMS consent forms, attached hereto as Schedule "F" and Schedule "G", respectively.

(19) I, Dr. Barrett, give my irrevocable consent to the College to provide all Chiefs of Staff with any information the College has that led to the circumstances of my entering into this Undertaking and any information arising from the monitoring of my compliance with this Underta

Current Tribunal Proceedings

No information available

Past Tribunal Proceedings

No information available

Other Notifications (2)

Source: Inquiries, Complaints and Reports Committee
Effective Date: 22 Oct 2021
Summary:
Effective August 13, 2024, Dr. Barrett has completed the required elements of his SCERP dated October 22, 2021.
 
Specified Continuing Education and Remediation Program:

A summary of a decision of the Inquiries, Complaints and Reports Committee in which the disposition includes a Specified Continuing Education and Remediation Program (“SCERP”) is required by the College By-laws to be posted on the register, along with a note if the decision has been appealed. A SCERP is one of the dispositions that the College’s Inquiries, Complaints and Reports Committee may make in connection with a matter before it, and this disposition requires the member to complete an education and remediation program specified for the member. A note will also be posted when all the elements of the SCERP have been completed. The summary will be removed from the register if the decision is overturned on appeal or review. Note that this requirement only applies to decisions arising out of a complaint dated on or after January 1, 2015 or if there was no complaint, the first appointment of investigators dated on or after January 1, 2015.
 
See PDF for the summary of a decision made against this member in which the disposition includes a  SCERP: 


Source: Member
Effective Date: 26 Jul 2019
Summary:
Summary of the Undertaking given by Dr. David Jang Barrett to the College of Physicians and Surgeons of Ontario, effective July 26, 2019:

A College investigation was conducted into Dr. Barrett’s prescribing of narcotics and controlled substances. As a result of the investigation:

Dr. Barrett must not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);

Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);

Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);

and as amended from time to time.

Dr. Barrett must post a clearly visible sign in the waiting rooms and each examination and consulting room, in all Practice Locations, which states as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:

Narcotic Drugs
Narcotic Preparations
Controlled Drugs
Benzodiazepines and Other Targeted Substances
Monitored Drugs

Further information may be found on the College of Physicians and Surgeons of Ontario website at www.cpso.on.ca 

Current Tribunal Proceedings

No information available

Past Tribunal Proceedings

No information available

Other Notifications (2)

Source: Inquiries, Complaints and Reports Committee
Effective Date: 22 Oct 2021
Summary:
Effective August 13, 2024, Dr. Barrett has completed the required elements of his SCERP dated October 22, 2021.
 
Specified Continuing Education and Remediation Program:

A summary of a decision of the Inquiries, Complaints and Reports Committee in which the disposition includes a Specified Continuing Education and Remediation Program (“SCERP”) is required by the College By-laws to be posted on the register, along with a note if the decision has been appealed. A SCERP is one of the dispositions that the College’s Inquiries, Complaints and Reports Committee may make in connection with a matter before it, and this disposition requires the member to complete an education and remediation program specified for the member. A note will also be posted when all the elements of the SCERP have been completed. The summary will be removed from the register if the decision is overturned on appeal or review. Note that this requirement only applies to decisions arising out of a complaint dated on or after January 1, 2015 or if there was no complaint, the first appointment of investigators dated on or after January 1, 2015.
 
See PDF for the summary of a decision made against this member in which the disposition includes a  SCERP: 


Source: Member
Effective Date: 26 Jul 2019
Summary:
Summary of the Undertaking given by Dr. David Jang Barrett to the College of Physicians and Surgeons of Ontario, effective July 26, 2019:

A College investigation was conducted into Dr. Barrett’s prescribing of narcotics and controlled substances. As a result of the investigation:

Dr. Barrett must not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);

Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);

Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);

and as amended from time to time.

Dr. Barrett must post a clearly visible sign in the waiting rooms and each examination and consulting room, in all Practice Locations, which states as follows:

IMPORTANT NOTICE

Dr. Barrett must not prescribe or administer any of the following:

Narcotic Drugs
Narcotic Preparations
Controlled Drugs
Benzodiazepines and Other Targeted Substances
Monitored Drugs

Further information may be found on the College of Physicians and Surgeons of Ontario website at www.cpso.on.ca 

Training

Medical School: St. George's University School of Medicine, 1992

Registration History

DETAILS DATE
Terms and conditions amended by Member. Effective: 10 Nov 2025
Terms and conditions amended by Member. Effective: 04 Oct 2024
Transfer of class of registration to: Restricted Certificate Effective: 26 Jul 2019
First certificate of registration issued: Independent Practice Certificate Effective: 02 Oct 2003
DETAILS: Terms and conditions amended by Member.
Date: Effective: 10 Nov 2025

DETAILS: Terms and conditions amended by Member.
Date: Effective: 04 Oct 2024

DETAILS: Transfer of class of registration to: Restricted Certificate
Date: Effective: 26 Jul 2019
DETAILS: Terms and conditions imposed on certificate by: Member
Date: Effective: 26 Jul 2019

DETAILS: First certificate of registration issued: Independent Practice Certificate
Date: Effective: 02 Oct 2003